Lisf of Poster Presenters May12 (Tue)
CD133: Still a marker of brain tumor stem cells?
CD133 negative glioma subpopulations grouped by different cell type markers display tumorgenicity in vivo.
Novel technique for establishment of glioblastoma stem cell line and pathological verification of distribution
and differentiation stage of tumor cells on its xenograft.
Therapeutic effect of genetically engineered mesenchymal stem cells in rat experimental leptomeningeal glioma
Chloroquine suppresses glioma cell viability and sensitizes radioresistant stem-like glioma cells to ionizing
Establishment and characterization of an experimental model of invasive glioma with highly radioresistant
Functional results after resection of glioma involving the supplementary motor area
The diagnostic impact of radical resection in the management of low-grade glioma
Experience with spectroscopy-supported stereotactic brain biopsy
Usefulness of FDG-PET-CT-guided stereotactic biopsy for brain tumors
Neuronavigation and brain biopsy. Surgical technique and comparison with traditional estereotaxic method.
The role of diffusion tensor image of the tumor resection
Usefulness of fiber tract navigation in tumor surgery adjacent to eloquent area
Preoperative functional imaging and intraoperative monitoring for improving resection rate of gliomas and
Awake Craniotomy and Electrophysiological Mapping in a High Field Intra-Operative MRI
New intraoperative MRI system in brain tumor surgery
Novel Surgical technique of radical removal for gliomas
DISSECTION AND SEPARATION OF HIGH GRADE GLIAL TUMORS FROM BRAIN TISSUE BY
USING METHALIC DISSECTOR WITH THE CAPABILITY OF PRODUCING VIBRATION
THE OPERATION OF PIAL SYNANGIOSIS IN THE SURGICAL TREATMENT OF MALIGNANT
The Clinical Results of Five Cases of Insular Tumor Resection
Keyhole surgery in the treatment of gliomas
Significance of porphyrins in blood and urine of brain tumor patients that underwent 5-ALA administration
Electroloaded dendritic cells with whole tumor lysate elicit enhanced induction of tumor-specific IFNγ
producing cells in patients with glioblastoma
Cytotoxic T lymphocytes induction with HLA-A2402-restricted glioma specific peptides
Characterization of a novel tumor-associated antigen for targeted toxin therapy in gliomas.
Tumoricidal bystander effect-mediated suicide gene therapy of glioma using genetically engineered bone
An efficient targeted gene therapy using brain tumor-specific promoter
LONG-TERM OUTCOME OF 23 CONSECUTIVE CHILDREN WITH PRIMARY INTRADURAL SPINAL
TUMORS TREATED AT THE MEDICAL UNIVERSITY OF VIENNA (1997-2008)
Effectiveness of multi-staged operations with combined chemotherapies for huge malignant infantile brain
WHICH THERAPY WORKS BETTER IN METASTATIC CHOROID PLEXUS CARCINOMAS?
99 Tc Sestamibi scan differentiates tumor from other contrast enhancing tissue in choroid plexus tumors - Case
Adjuvant chemoradiation for mixed germ cell tumors
OVER A 10-YEAR SURVIVAL AND COMPLETE RESPONSE OF A PATIENT WITH DIFFUSE
INTRINSIC BRAINSTEM GLIOMA (DBSG) TREATED WITH ANTINEOPLASTONS (ANP)
Improved response of pontine glioma with simultaneous radiochemotherapy: results of a retrospective image
Tactics For Diagnosis and Surgical Treatment of Brain Stem Tumors
Profile of Patients with Medulloblastoma at the Philippine General Hospital: a Six-Year Review
Results of treatment for medulloblastoma in our institute
Can absolute lymphocyte count really be a prognostic indicator for overall survival in patients with
Integrating Complexity, Therapeutic Recreation, and Radiotherapy in Multidisciplinary Medical Team on
Reducing Anesthesia/Sedation Requirement for Toddlers and Young Children with Brain Tumor
Implications of Complexity: Leisure Participation on Primary Caregivers and Hospitalized Children with Brain
May13 (Wed)
Endothelial Cell Transdifferentiation of Human Glioma Stem/ Progenitor Cells In vitro
The New Diagnosis and Treament of Pituitary Apoplexy
THE MIR-17/92 POLYCISTRON IS AMPLIFIED AND UP-REGULATED IN SONIC HEDGEHOG-
DRIVEN MEDULLOBLASTOMAS AND INDUCED BY N-MYC IN SONIC HEDGEHOG-TREATEDCEREBELLAR NEURAL PRECURSORS
MULTIPLE RECURRENT GENETIC EVENTS CONVERGE ON CONTROL OF HISTONE LYSINE
MEDIP-CHIP AND MEDIP-SEQ IDENTIFY NOVEL EPENDYMOMA TUMOUR SUPPRESSOR GENES
THROUGH DELINEATION OF THE EPENDYMOMA EPIMETHYLGENOME
Clinical Diagnosis of Optic Nerve Hemangioblastoma
Gene expression meta-analysis identifies grading and survival markers in anaplastic glioma
Multiparameteric MR approach for tissue characterization of patients with GBM
NG2 Expression Establishes a Link Between Neural Precursors and Cancer Stem Cells in Glioblastoma
UNUSUAL CASE OF RADIATION-INDUCED GROWING TERATOMA SYNDROME
Causes and correlates of distress and major depression in high-grade glioma
BEVACIZUMAB PLUS ERLOTINIB IN RECURRENT HIGH-GRADE GLIOMA: A PHASE II TRIAL
PATIENT FUNCTIONAL STATUS IS STRONGEST CORRELATE OF CHALLENGING BEHAVIOUR
Detailed prospective neuropsychological, activity of daily living and endocrine function assessment in children
with craniopharyngioma treated with stereotactic conformal radiotherapy
Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases
Steroid Requirements during Radiotherapy for Malignant Gliomas
Mutational profiling of high grade gliomas reveals inactivating mutations in IDH1
Genomic Profiling of Intracranial Germ Cell Tumors with Single Nucleotide Polymorphism Array
PRESENCE OF AN ALTERNATIVE LENGTHENING OF TELOMERE (ALT) MECHANISM AS A
FAVORABLE PROGNOSTIC MARKER IN PATIENTS WITH GLIOBLASTOMA
Long Term Follow Up of Patient with Acromegaly after LINAC Radiosurgery
DO MEDULLOBLASTOMAS IN ADOLESCENTS HAVE A DISTINCT MOLECULAR SIGNATURE &
Aberrant expression of GDF-15 contributes to proliferation and immune escape of malignant gliomas
Personalized chemotherapy based on O6-methylguanine-DNAmethyltransferase (MGMT) expression pattern for
CDK4/6 SMALL MOLECULE INHIBITOR PD-0332991 DEMONSTRATES ANTI-TUMOR ACTIVITY
AGAINST AN INTRACRANIAL GLIOBLASTOMA XENOGRAFT LACKING p16 FUCNTION
PATIENT-SPECIFIC VIRTUAL CONTROLS CAN BE USED TO SIMULATE AND PREDICT
RESPONSE TO RADIATION THERAPY IN INDIVIDUAL GLIOBLASTOMA PATIENTS
Autophagy Induced by Valproic Acid is Associated with Oxidative Stress in Glioma Cell Lines
Management of pituitary adenoma with stereotactic radiotherapy at Princess Margaret Hospital.
Genomewide Analysis of Loss of Heterozygosity in Glioblastoma using the SNP mapping array and the PCR
Molecular allelokaryotyping of malignant glioma by high-resolution single nucleotide polymorphism (SNP)
An ANOCEF genomic and transcriptomic microarray study of the response to radiotherapy or to alkylating first-
line chemotherapy in glioblastoma patients.
Selective Expression of a Subset of Neuronal Genes in Oligodendrogliomawith Chromosome 1p Loss
LOSS OF HETEROZIGOSITY AT 1p-19q INDUCES A GLOBAL CHANGE IN OLIGODENDROGLIAL
Functional analysis of the proteome related to the chemotherapy sensitivity in anaplastic oligodendroglioma and
Establish the overall proteins reference database of human normal pituitary using 2D-HPLC combined with
CD52 protein may be a potential tumor marker of hemangioblastoma in central nerval systerm with cDNA
microarray filtration of the gene expression profiles
Genome-wide analysis of gene expression during brain metastasis formation
Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1α
Effects of hypoxia on expression of a panel of stem cell and chemosensitivity markers in glioblastoma cell line-
Cell motility features are identified in the CD133-positive glioma and endothelial progenitor cells
GLIOBLASTOMA TUMOUR INITIATING CELLS DEMONSTRATE VEGF BUT NOT PDGF
Establishment of artificial Glioblastoma initiating cells in mouse
CD133 ON STEM CELLS IS REQUIRED FOR APOPTOTIC INDUCTION IN GLIOMAS
Tumor stem-like associated antigens and their irradiations improve the effect of dendritic cell-based vaccination
Immunosuppressive B7-H1 Protein is Expressed by Differentiated Glioma Cells but not Glioma Stem Cells
B7-H1 is correlated with the malignancy grade of human astrocytic tumors but it is not the privilege of brain
EXPRESSION LEVEL OF STEM CELL MARKERS IS ASSOCIATED WITH THE SOURCE OF
NEUROSPHERE MEDIA USED FOR GLIOBLASTOMA STEM CELL CULTURE.
AN EVALUATION OF THE NEURAL STEM CELL MARKER NG2 AS A BIOMARKER OF DISEASE IN
Gene Therapy Using TRAIL-Secreting Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells against
Brain Easy Analysis Tool For 201Tl SPECT in Brain Tumors
123I-IMP SPECT in Brain Tumor: Anatomical Standardized Statistical Mapping
The application of Susceptibility Weighted magnetic resonance Imaging (SWI) to diagnosis and treatment of
Choline-enhanced proton MRS of brain tumors
Preoperative evaluation by proton magnetic resonance spectroscopy in the grading of gliomas
Modified 11C-Methionine PET imaging to distinguish radiation necrosis from recurrent glioma
Matching analysis of PET and chemical shift imaging on proton MRS in patients with supratentorial glioma
Augmenting Intraoperative MRI with Preoperative DTI and fMRI by Simulation of Brain Deformation Using
Mathematical Model Based on Thin-Plate Splines:A Preliminary Research
The Value of rCBV Ratio in Perfusion MR for Differentiating Radiation Necrosis from Tumor Recurrence in
High Grade Glioma; comparison with 18F-FDG and 11C-Methionine PET
Evaluation of glioma grading on MR imaging: Diagnostic value of minimum apparent diffusion coefficient
compared with positron-emission tomography
Glioblastoma treated with postoperative radio-chemotherapy: Prognostic value of apparent diffusion coefficient
DIFFUSION-WEIGHTED IMAGING IN PATIENTS WITH GLIOBLASTOMA MULTIFORME TREATED
Evaluation of anti-angiogenic therapy response in patients with GBM; a Homodynamic Response Imaging study
PROGNOSTIC SIGNIFICANCE OF GROWTH KINETICS IN NEWLY DIAGNOSED GLIOBLASTOMA:
A ROLE FOR PATIENT-SPECIFIC VIRTUAL CONTROLS
Effectiveness of Gorei-San ( Wuling San ) for eliminating brain edema due to malignant brain tumors
Image guided Convection-enhanced delivery of nimustine hydrochloride (ACNU) in recurrent glioma patients
Convection enhanced delivery of nimustine hydrochloride (ACNU) with systemic administration of
temozolomide in recurrent glioma patients
SURVIVAL OF PATIENTS WITH GLIOBLASTOMA MULTIFORME AT HARTFORD HOSPITAL
SINGLE CENTER SURVIVAL OUTCOMES OF 167 GLIOBLASTOMA PATIENTS: BEFORE AND
Clinical outcomes of adult supratentorial grade 3 malignant gliomas in a single institution
Glucocorticoid-induced bone fracture in progressive glioma patients
NEWLY DIAGNOSED PREGNACY AND GLIOBLASTOMA MULTIFORME (GBM): AN ETHICAL
Vntricular and Leptomeningeal Seeding in a Patient with Medullary Anaplastic Oligodendroglioma
Long-term outcome of low-grade gliomas treated with radiotherapy-deferring therapeutic policy
Considerations for diagnosis and treatment of classical gliomatosis cerebri
Growth rates of metastatic brain tumors in non-small cell lung cancer; estimation from micro-metastasis
Prognostic factors in 57 patients with metastastic brain tumors from breast cancer.
Intramedullary spinal cord metastasis in breast carcinoma, case report.
Spinal cord metastasis of adenocarcinoma, case Report
Complete response of a large recurrent metastatic brain tumor treated by CyberKnife: a case report and review
Continuous intrathecal treatment with methotrexate via "Ventricular port" for leptomeningeal dissemination of
Population Based Epidemioly of Central Nervous System (CNS) malignancies in the Girona province (Spain).
Results of an 11 years survey (1994-2004).
THE FIRST FINGERPRINTS OF NEUROONCOLOGY IN PREHISTORIC ERA; PREHISTORIC
TRAPENATED SKULLS MAY BE THE FIRST ATTACT TO TREAT TUMORS IN NEUROONCOLOGY
Expanded Endonasal Resection of Supra- and Extra-Sellar Lesions
Extended endoscopic endonasal transsphenoidal approach for skull base lesion- Availability of multilayered
Results of Extended TSA to anterior skull base
Two-Surgeons Technique for infratemporal fossa tumor; Simultaneous lateral transzygomatic and endoscopic
Application of Endoscopes in minimally invasive neurosurgery
Clinical correlation between peritumoral edema and various factors in meningioma.
Meningioma operations in the elderly patients: efficient way to internal decompression
A 57-patient experience on the surgical strategies of petroclival meningiomas
Retrospective analysis of the post-operative outcome of petroclival meningiomas
Advantages of the Pterional approach for Olfactory groove and Tuberculum Sellae Meningiomas
Meningioma arising from the lateral recess of 4th ventricle
Surgical management for trigeminal schwannoma
Lateral or anterolateral approach for large dumbbell-shaped cervical neurinoma
Clinical Course of Piuitary Adenoma after Apoplexy
Efficacy and Safety of Cabergoline as a First Line Treatment for Invasive Giant Male Prolactinoma
Comparison of lateral and superior walls of the pituitary fossa with clinical emphasis on pituitary adenoma
METASTATIC ACTH PRODUCING PITUITARY CARCINOMA (PCa) TREATED WITH
TEMOZOLOMIDE(T): CASE REPORT AND REVIEW OF THE LITERATURE
Isolated Ocular Paresis in the Pituitary Adenoma: Review of 4 cases
The effective treatment of craniopharyngioma using highly conformal hypofractionated stereotactic irradiation
Lymphocytic hypophysitis with reference to MR imaging
Central Neurocytoma Presenting with Intraventricular Hemorrhage
Clinical Treatment of Intracranial Malignant Nerve Sheath Tumors
A rare tumor-like lesion of peripheral nerve sheath in an unusual site. Neuromuscular choristoma of intraorbital
retrobulbar conus. A case report and literature review.
Clinical Experiences Of Intracranial Hemangioblastoma
Surgical management of CNS hemangioblastomas in von Hippel-Lindau disease
Clinical Diagnosis and Treatment of Hypothalamic Hamartoma in Children
Clinical Diagnosis and Treatment of Third Ventricle Cavernous Angioma
MULTIFOCAL, PROTEINACEOUS CNS DEPOSITS MIMICKING NEOPLASIA: REPORT OF AN
UNUSUAL CEREBRAL AND CEREBELLAR AMYLOIDOMA WITH LONG LASTING CLINICALHISTORY
Primary Burkitt lymphoma of CNS in an immunocompetent old woman: a rare case report and review literatures
Primary leptomeningeal melanomatosis in a 31-year-old woman
Primary Intracerebral Malignant Fibrous Histiocytoma, Case report
Incidentally discovered Clival Pseudomeningocele : A Case Report
Malignant brain tumor in a patient with AIDS
Glioblastoma developed in a cured pediatric CNS leukemia
A PATIENT WITH GLIOBLASTOMA MULTIFORME AND A LEFT CERVICAL MASS- A CASE
Early detection of the venous thromboembolism in glioma patient
2 CASES OF EXTRADURAL GLIOBLASTOMA MULTIFORME PRESENTING AS TRIGEMINAL
NEURALGIA; PATTERNS OF MOLECULAR TARGETS OF INVASIVENESS.
Pontine Cryptococal granuloma in a healthy, non-immunocompromised patient-Case report-
Prognositic analysis of 220 patients with intramedullary spinal cord ependymomas
The Rational Neurosurgical Treatment of pineal region tumors
Conservative Management of Pseudomeningoceal Formation after Posterior Fossa Tumor Surgery in Children
Posterior Fossa Tumors with Hydrocephalus: Outcome of Surgery without CSF Diversion
Atypical meningioma in French West Indies
Atypical Rathke’s cleft cyst with calcification
May14 (Thu)
The correlation and prognostic significance of MGMT promoter methylation and the MGMT protein in
Relevance of MSP assay for the detection of MGMT promoter hypermethylation in glioblastomas
Clinical significance of polymorphism of DNA repair gene MGMT in Glioblastomas
IMMUNOHISTOCHEMICAL ASSESSMENT OF O6-METHYLGUANINE DNA METHYLTRANFERASE
MGMT methylation status may predict survival in elderly patients with newly diagnosed glioblastoma (GBM)
Methylation-sensitive high resolution melting analysis :a new quantitative assessment of MGMT promoter
MGMT testings for temozolomide efficacy on glioblastoma
A NOVEL AND SPECIFIC INHIBITOR OF MGMT TRANSCRIPTION INCREASES THE SENSITIVITY
OF GLIOMA CELL LINES TO TEMOZOLOMIDE TREATMENT.
Mechanism of Thalidomide to enhance the cytotoxicity of Temozolomide in U251-MG glioma cells in vitro
Neural differentiation markers expression in human glioblastomas may predict their response to chemotherapy
Extended use of temozolomide based on O6-methylguanine-DNAmethyltransferase (MGMT) expression pattern
for glioma patients: experience of 17 cases
Pysosequencing: a good option for MGMT analysis.
ANGIOGENIC POTENTIAL OF LOW GRADE OLIGODENDROGLIOMAS IS AN IMPORTANT
Identification of a novel small molecule HIF-1α translation inhibitor
PHASE I STUDY OF VANDETANIB, IMATINIB MESYLATE AND HYDROXYUREA FOR
A PHASE I STUDY OF SUNITINIB PLUS IRINOTECAN IN THE TREATMENT OF PATIENTS WITH
A PHASE IB TRIAL OF CEDIRANIB IN ADDITION TO STANDARD TEMOZOLOMIDE AND
RADIATION THERAPY IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA
THE POTENTIAL BENEFIT OF NEOADJUVANT AND EXTENDED-ADJUVANT TEMOZOLAMIDE
WITH THE STUPP-REGIMEN IN THE TREATMENT OF GLIOBLASTOMA
Dose dense one week on/ one week off temozolomide in recurrent glioma.
CLINICAL TRIAL WITH TEMOZOLOMIDE IN AN ALTERNATING WEEKLY REGIMEN AGAINST
RECURRENT MALIGNANT GLIOMAS-A PRELIMINARY REPORT
Safety and efficacy of near-continuous dose-dense temozolomide (Tegwondo) for recurrent gliomas
Pharmaceutical control of temozolomide chemotherapy with original leaflets and administration history
Safety and efficacy of temozolomide treatment with newly diagnosed glioblastoma in Japan. A multicenter
RETROSPECTIVE ANALYSIS OF GLIOBLASTOMA (GBM) PATIENTS TREATED WITH
TEMOZOLOMIDE (TMZ)-RADIOTHERAPY FOLLOWED BY TMZ FOR 2 YEARS OR UNTILPROGRESSION: SURVIVAL ANALYSIS
Pseudprogression or tumor progression in gliomas: what kinds of diagnostic tools are more reliable?
Hypofractionated high-dose irradiation by IMRT concurrent with prophylactic intrathecal chemotherapy for the
A Pilot Safety Trial of Hypofractionated Radiation Therapy plus Concomitant and Adjuvant Temozolomide for
Upfront chemotherapy for gliomas deleting 1p and 19q followed by second-look removal and/or radiotherapy at
Benefit of Chemotherpy in Anaplastic Astrocytomas
Therapy-related myelodysplastic syndrome following treatment for malignant glioma
Teniposide and Nimustine Regimen for Malignant Gliomas with O6-methylguanine-DNA methyltransferase
(MGMT) Negative Expression: Experience of 18 cases
Safety profile of carmustine wafer treatment in first line treatment of malignant glioma with carmustine implants
followed by concomitant radiochemotherapy
THE GROWTH PATTERN OF RECURRENT GLIOBLASTOMA AFTER GLIADEL(TM) WAFER
Pre-radiation chemotherapy with ACNU-CDDP in patients with newly diagnosed glioblastoma: a retrospective
A concurrent association radiation therapy fotemustine for newly diagnosed malignant gliomas, a phase II.
TOXICITY PROFILE OF VALPROATE AND ETOPOSIDE METRONOMIC CHEMOTHERAPY
Combination therapy with carboplatin and etoposide for recurrent malignant gliomas
Phase II Study of Ifosfamide, Carboplatin and Etoposide for Patients with Glioblastoma at first relapse
PHASE II STUDY OF ANTINEOPLASTONS A10 AND AS2-1 IN PATIENTS WITH BRAINSTEM
Treatment of primary malignant gliomas and meningiomas with ruta/calc phos
Leptomeningeal gliomatosis in patients treated with bevacizumab
Response to intrathecal infusions of Depocyte in secondary diffuse leptomeningeal gliomatosis. A case report.
New therapeutic approach for brain tumors: intranasal administration of Ras inhibitor monoterpene perillyl
Cetuximab does not influence Serum Magnesium Homeostasis in Patients with Glioblastoma Multiforme treated
with concomitant Radiotherapy and Temozolomide
A retrospective single institutional analysis of cilengitide (CGT) and chemotherapy for heavily pre-treated
recurrent glioblastoma multiforme (GBM).
Cilengitide modulates attachment and viability of human glioma cells, but not sensitivity to irradiation or
METABOLIC FACTORS GOVERN THE CYTOTOXIC POTENTIAL OF EGFR INHIBITION IN HUMAN
AN EPIGENETIC GENOME-WIDE SCREEN IDENTIFIES THE SFRP FAMILY OF WNT SIGNALING
INHIBITORS AS NOVEL TUMOR SUPPRESSOR GENES IN MEDULLOBLASTOMA
SILENCING OF NEURONAL DIFFERENTIATION GENES REVEALED BY PROFILING THE
Pediatric intracranial germ cell tumors of different prognosis outcomes and ethnic background inherit
characteristic embryonic stem cell traits and microRNAome profiles
The frequent expression of ARF-BP1 in primary intracranial germ cell tumors
Frequent single nucleotide polymorphism (SNP) of BCL10 and association with poor prognosis in primary
EXPRESSION PROFILES OF MICRORNA IN PEDIATRIC MALIGNANT GLIOMAS
STRESS LEVELS AMONG PARENTS OF CHILDHOOD BRAIN TUMOR SURVIVORS
MULTI-TIERED INTERVENTION STUDY FOR PATIENTS, CARERS AND HEALTH PROVIDERS TO
ADDRESS CHALLENGING BEHAVIOURS AFTER BRAIN TUMOUR
Knowledge and Attitudes On The Diagnosis, Treatment And Prognosis Among Patients With Brain Tumor And
Management of Primary Malignant Brain Tumors During Pregnancy
Cancer Stem Cells from Glioblastoma Multiforme Patients
Characterization of Cancer Stem-like Cells Derived from Human Glioblastomas
Characterization of cancer stem cells in human glioblastomas
Characterization of tumor stem cells isolated form human glioblastoma multiforme
STAT3 SERINE727 ACTIVATION IN GLIOMA CANCER STEM CELLS
ENHANCEMENT OF STEM-LIKE GLIOMA NEUROSPHERE RADIORESPONSE BY GEFITINIB: BY
INCREASED DNA DAMAGE AND REDUCED DNA REPAIR CAPACITY
Inhibition of tumor growth and angiogenesis by targeting CXCL12/CXCR4 axis in stem cell-like glioma cells
Cultivation and identification of the cells from central nervous system hemangioblastomas and its stem cells
Screen and identify the critical proteins of central nervous system hemangioblastoma tumor cells using on-line
capillary 2D-HPLC combined with LTQ-Orbitrap MS
Notch1 induces more expression of DLL1 in U251MG glioma cell line
The functional analysis of a novel KDR (VEGFR II)-PDGFR-alpha fusion gene in glioblastoma: From
Isolation and Characterization of an N-Linked Oligosaccharide That Is Increased in Glioblastoma Tissue and
Inhibition of glioma proliferation by modified p53 protein fused with protein transduction domains
Expression of the lysosomal-associated membrane protein-1 (LAMP-1) in astrocytomas
EVALUATION OF ELK-1 ACTIVATION BY PHOSPHATIDYLINOSITOL 3-KINASE/AKT PATHWAY
ANTINEOPLASTONS INHIBIT MCM COMPLEX IN GLIOBLASTOMA CELLS
Enhanced expression of NADPH Oxidase Nox4 in human gliomas and its roles in cell proliferation and survival
EXPRESSION PATTERN OF EGFRS, INTEGRINS, AND RELATED MOLECULES IN HUMAN
GLIOBLASTOMA VERSUS INTRACEREBRAL LUNG ADENOCARCINOMA METASTASIS
Inhibition of LRIG3 gene expression via RNA interference modulates the proliferation, cell cycle, cell
apoptosis, adhesion and invasion of glioblastoma cell
Promyelocytic leukemia protein induces apoptosis by the repression of NFκB activation in glioblastoma
The cellular oncogene ets-1 counteracts p53 tumour suppressor activity by affecting the level of p53 protein.
Cooperative cytotoxicity by HDAC inhibitors and RTKIs: induction of Cx43 in GBM cells
A MDR1 (ABCB1) GENE SINGLE NUCLEOTIDE POLYMORPHISM PREDICTS OUTCOME OF
TEMOZOLOMIDE TREATMENT IN GLIOBLASTOMA PATIENTS
Diversity of DNA damage response of astrocytes and glioblastoma cell lines with various p53 status to treatment
The decreased expression of GANP is associated with chromosomal instability in malignant gliomas
ELK4 NEUTRALISATION SENSITISES HIGH GRADE GLIOMA TO APOPTOSIS THROUGH DOWN
REGULATION OF THE ANTI-APOPTOTIC PROTEIN MCL-1
xCT as a potential molecular target in glioblastoma multiforme
A novel MMAC/PTEN gene mutation in a GBM patient
Attraction of hematopoietic progenitor cells by experimental gliomas in vivo: Towards a cell-based therapy for
OLIGODENDROGLIOMAS WITH LOH 1P/19Q: IDENTIFYING GENES ASSOCIATED WITH
ASSOCIATION OF 7q34 COPY NUMBER GAINS AND KIAA1549-BRAF GENE FUSIONS WITH
IDH-1 mutations are frequent in low grade glioma and do not correlate with outcome to temozolomide
PPAR-γ activators: Off-target against TGF-β mediated glioma cell migration and brain invasion
Tight junction protein Occludin in human brain tumors: Radiological correlation and prognostic implication on
Expression of the TIMP-1 interacting cell surface protein CD63 in astrocytomas
Molecular Variations in Tumor-Host Interactions between Invasive and Angiogenic Phenotype in High Grade
MULTI-MODAL IMAGING OF ACUTE AND CHRONIC UP-REGULATION OF HYPOXIA-INDUCIBLE
Relationship between ABC transporter proteins and vasculogenesis in glioblastomas
Histone deacetylase inhibitor, valproic acid inhibits glioma angiogenesis in vitro and in vivo in the brain
The p14ARF tumor suppressor inhibits Glioma-Induced Angiogenesis by a Novel Mdm2/Sp1/Timp3 Signaling
Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by
Hypoxia-induced Stat3 activity contributes the HIF-1, VEGF, MMP2 and TWIST expression in human
glioblastoma, which induce angiogenesis and cell migration.
NOVEL MONOCLONAL ANTIBODY 13R2.C3 AGAINST IINTERLEUKIN 13 RECEPTOR ALPHA-2
REVEALS A SPECIFIC AND MORE WIDE-SPREAD EXPRESSION OF THE RECEPTOR IN VARIOUSBRAIN TUMORS
Synergistic effect of human IFN-beta and TMZ on malignant glioma cell lines
The role of chemokine SDF-1/CXCR4/CXCR7 for glioblastoma angiogenesis and glioblastoma derived
Soluble CD70 Confers an Immune-Mediated Survival Advantage in Experimental Glioblastoma
Aberrant Hypermethylation of CpG islands Profile of Cell Cycle Regulatory Genes in Malignant Astrocytomas
An in vitro study of selected synthetic chalcone analogues activity against Ben-Men-1 meningioma cell line
New CCM1 gene mutations in Chinese sporadic intracranial cavernous angioma patients
The functional role of eIF4E in primary central nervous system lymphoma
Is it Total removal of glioblastoma possible? - tumor cell infiltration from autopsy brain
Clinical significance of vasculogenic mimicry in human gliomas
Validation of prognostic and therapeutic worth of molecular markers by routine tools in diagnostic and clinical
neuropathology: a study of 193 glioblastomas.
OLIGODENDROGLIAL TUMOR CLASSIFICATION: PHENOTYPE vs GENETIC SIGNATURE
HISTOLOGIC ANAPLASIA IN SPORADIC AND NF1-ASSOCIATED PILOCYTIC ASTROCYTOMAS
APPLICATION OF A CYTOGENETC PROGRESSION SCORE (GPS), TUMOR LOCATION AND
GENETIC PROGRESSION IN MENINGIOMAS: HACETTEPE EXPERIENCE
Targeting the tumor stroma a novel therapeutic strategy based on separate analysis of the malignant and stromal
Therapeutic efficacy of a polymeric micellar doxorubicin infused by convection-enhanced delivery against
Label-free Differentiation of individual human glioma cells by optical FTIR spectroscopic imaging
Application of multiple-stage tandem imaging mass spectrometry to the evaluation of lipids in a rat brain C6
Spectroscopic imaging of cerebral micrometastases in a murine model
Significance of NMR based metabolomics (metabolome) for the prediction of malignant type meningioma using
the analysis of water and lipid-soluble metabolites
Role of Proteomic study of CSF as a diagnostic tool in the patients with meningiomas
IL-6 in meningioma; Expression is correlated with peritumoral edema and VEGF
Antitumor effect of humanized anti-IL-6 receptor antibody (tocilizumab) on glioma cell proliferation
The Plasma Concentration of ET-1 in the Brain Tumors
Plasma Ig E levels correlate with diagnosis and response to therapy in glioma patients
Promoter methylation profiles of six tumor-related genes in various brain tumors
SHORT COURSE OF RADIOTHERAPY AND CONCOMITANT TEMOZOLOMIDE IN PATIENTS
AFFECTED WITH GLIOBLASTOMA WITH V-VI PROGNOSTIC CLASSES. A PILOT STUDY
Assessment of 11C-methionine PET Changes for Monitoring Therapeutic Response Following Simultaneous
Integrated Boost Technique for Glioblastoma Multiforme
RECURRENCE PATTERN AFTER [(18)F]FLUOROETHYLTYROSINE- POSITRON EMISSION
TOMOGRAPHY-GUIDED RADIOTHERAPY FOR HIGH-GRADE GLIOMA.
Rhabdomyosarcoma as a late complication of Stereotactic Radiotherapy in the patient with Neurofibromatosis
RADIATION-INDUCED CEREBRAL CAVERNOUS HEMANGIOMAS IN ADULTS.
Hematotoxicity of craniospinal irradiation in adult patients
Inspection about recurrence and progressing dementia after WBRT to metastatic brain tumor - Problem
Novalis Shaped Beam Radiosurgery for cranial and spinal tumors: 8 years of experience in Korea
ULTRAFRACTIONATED RADIATION THERAPY (3 DOSES PER DAY) FOR INOPERABLE
GLIOBLASTOMAS. A NEW AND PROMISING REGIMEN.
STEREOTACTIC RADIOSURGERY (SRS) IN RECURRENT HIGH-GRADE GLIOMA
Treated with CyberKnife Stereotactic Radiosurgery: Two CyberKnife Centers Experience
Peritumoral edema after Cyberknife radiosurgery for meningioma: Report of two cases and Review of literature.
Preliminary results of initially trated patients-FEASIBILITY OF APPLYING THE SYNERGY-S SYSTEM
FOR STEREOTACTIC IRRADIATION SPINAL TUMORS
DOSE-VOLUME ANALYSIS OF WHOLE VENTRICULAR IRRADIATION BY PROTON BEAM
COMPARING WITH INTENSITY MODULATED RADIOTHERAPY AND STANDARD PHOTONTHERAPY
IN VIVO BIODISTRIBUTION OF BORON AFTER INTRAVENOUS 4-
DIHYDROXYBORYLPHENYLALANINE-FRUCTOSE (BPA-F) INFUSION IN MENINGIOMA ANDSCHWANNOMA: A FEASIBILITY STUDY FOR BORON NEUTRON CAPTURE THERAPY(BNCT)
Clinical Results of Modified Boron Neutron Capture Therapy for Malignant Glioma
BRAIN TUMORS BRACHYTHERAPY BY USING RIGID IR192 CATHETER
IMAGING FEATURES IN PARENCHYMAL LYMPHOMATOUS MASSES IN BRAIN: PRIMARY CNS
LYMPHOMA OR SYSTEMIC INVOLVEMENT OF THE BRAIN?
Long-term Survival in Primary CNS Lymphoma Treated by High-dose Methotrexate Monochemotherapy: role
of STAT6 Activation as prognostic determinant
Treatment for primary CNS lymphoma with high-dose MTX and salvage therapy with ESHAP
Treatment of Primary Central Nervous System Lymphoma with Temozolomide, Vincristine, Doxorubicin,
Intravenous rituximab combined with temozolomide as a second line therapy for CD20 positive primary central
Maintenance therapy using rituximab for primary central nervous system lymphoma
Diagnosis and Management of Spinal Extradural Non-Hodgkin Lymphoma:Analysis of Three Cases and Review
FDA-approved patient labeling STAXYN® (stax-in) • Or any family members have a rare heart condition known as prolongation of the QT (vardenafil HCl) orally disintegrating tablets • Have liver problems. • Have kidney problems and require dialysis. Read the Patient Information about STAXYN before you start taking it and again each time you get a refill. There may be new in
Should echinacea be taken on a daily basis?The question whether echinacea should be used on along-term or continual basis has not been adequatelyanswered. The usual recommendation with long-termuse is 8 weeks on followed by one week off. Researchsuggests that the people most likely to benefit fromusing echinacea for prevention are those with weakerimmune systems who are more prone to infection.